 | • レポートコード：GIR-2104Z10297 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、経口コレラワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。経口コレラワクチンの種類別市場規模（Shanchol、Dukoral、Vaxchora、その他）、用途別市場規模（病院、研究所＆学術研究所、製薬・バイオテクノロジー企業、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・経口コレラワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：PaxVax、Sanofi、Valneva、EuBiologics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：Shanchol、Dukoral、Vaxchora、その他 ・用途別分析2016年-2026年：病院、研究所＆学術研究所、製薬・バイオテクノロジー企業、その他 ・経口コレラワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・経口コレラワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・経口コレラワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・経口コレラワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・経口コレラワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oral Cholera Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oral Cholera Vaccine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Oral Cholera Vaccine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Oral Cholera Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Shanchol
Dukoral
Vaxchora
Others
Market segment by Application can be divided into
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
The key market players for global Oral Cholera Vaccine market are listed below:
PaxVax
Sanofi
Valneva
EuBiologics
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Oral Cholera Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Cholera Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Shanchol
1.2.3 Dukoral
1.2.4 Vaxchora
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Cholera Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Global Oral Cholera Vaccine Market Size & Forecast
1.4.1 Global Oral Cholera Vaccine Sales in Value (2016-2026))
1.4.2 Global Oral Cholera Vaccine Sales in Volume (2016-2026)
1.4.3 Global Oral Cholera Vaccine Price by Type (2016-2026) & (USD/Unit)
1.5 Global Oral Cholera Vaccine Production Capacity Analysis
1.5.1 Global Oral Cholera Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Oral Cholera Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Cholera Vaccine Market Drivers
1.6.2 Oral Cholera Vaccine Market Restraints
1.6.3 Oral Cholera Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 PaxVax
2.1.1 PaxVax Details
2.1.2 PaxVax Major Business
2.1.3 PaxVax Oral Cholera Vaccine Product and Services
2.1.4 PaxVax Oral Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Oral Cholera Vaccine Product and Services
2.2.4 Sanofi Oral Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Valneva
2.3.1 Valneva Details
2.3.2 Valneva Major Business
2.3.3 Valneva Oral Cholera Vaccine Product and Services
2.3.4 Valneva Oral Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 EuBiologics
2.4.1 EuBiologics Details
2.4.2 EuBiologics Major Business
2.4.3 EuBiologics Oral Cholera Vaccine Product and Services
2.4.4 EuBiologics Oral Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Oral Cholera Vaccine Sales by Manufacturer
3.1 Global Oral Cholera Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Oral Cholera Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Oral Cholera Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Cholera Vaccine Manufacturer Market Share
3.4.2 Top 6 Oral Cholera Vaccine Manufacturer Market Share
3.5 Global Oral Cholera Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Oral Cholera Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oral Cholera Vaccine Market Size by Region
4.1.1 Global Oral Cholera Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Oral Cholera Vaccine Revenue by Region (2016-2026)
4.2 North America Oral Cholera Vaccine Revenue (2016-2026)
4.3 Europe Oral Cholera Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Oral Cholera Vaccine Revenue (2016-2026)
4.5 South America Oral Cholera Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Oral Cholera Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Oral Cholera Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Oral Cholera Vaccine Revenue by Type (2016-2026)
5.3 Global Oral Cholera Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Oral Cholera Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Oral Cholera Vaccine Revenue by Application (2016-2026)
6.3 Global Oral Cholera Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Oral Cholera Vaccine Sales by Type (2016-2026)
7.2 North America Oral Cholera Vaccine Sales by Application (2016-2026)
7.3 North America Oral Cholera Vaccine Market Size by Country
7.3.1 North America Oral Cholera Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Oral Cholera Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Oral Cholera Vaccine Sales by Type (2016-2026)
8.2 Europe Oral Cholera Vaccine Sales by Application (2016-2026)
8.3 Europe Oral Cholera Vaccine Market Size by Country
8.3.1 Europe Oral Cholera Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Oral Cholera Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Oral Cholera Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Oral Cholera Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Oral Cholera Vaccine Market Size by Region
9.3.1 Asia-Pacific Oral Cholera Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Oral Cholera Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Oral Cholera Vaccine Sales by Type (2016-2026)
10.2 South America Oral Cholera Vaccine Sales by Application (2016-2026)
10.3 South America Oral Cholera Vaccine Market Size by Country
10.3.1 South America Oral Cholera Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Oral Cholera Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oral Cholera Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Oral Cholera Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Oral Cholera Vaccine Market Size by Country
11.3.1 Middle East & Africa Oral Cholera Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Oral Cholera Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Oral Cholera Vaccine Typical Distributors
12.3 Oral Cholera Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Oral Cholera Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Oral Cholera Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. PaxVax Basic Information, Manufacturing Base and Competitors
Table 4. PaxVax Major Business
Table 5. PaxVax Oral Cholera Vaccine Product and Services
Table 6. PaxVax Oral Cholera Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Major Business
Table 9. Sanofi Oral Cholera Vaccine Product and Services
Table 10. Sanofi Oral Cholera Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Valneva Basic Information, Manufacturing Base and Competitors
Table 12. Valneva Major Business
Table 13. Valneva Oral Cholera Vaccine Product and Services
Table 14. Valneva Oral Cholera Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 16. EuBiologics Major Business
Table 17. EuBiologics Oral Cholera Vaccine Product and Services
Table 18. EuBiologics Oral Cholera Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Oral Cholera Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
Table 20. Global Oral Cholera Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Oral Cholera Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Oral Cholera Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Oral Cholera Vaccine Production Site of Key Manufacturer
Table 24. Global Oral Cholera Vaccine Sales by Region (2016-2021e) & (K Units)
Table 25. Global Oral Cholera Vaccine Sales by Region (2021-2026) & (K Units)
Table 26. Global Oral Cholera Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 27. Global Oral Cholera Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 28. Global Oral Cholera Vaccine Sales by Type (2016-2021e) & (K Units)
Table 29. Global Oral Cholera Vaccine Sales by Type (2021-2026) & (K Units)
Table 30. Global Oral Cholera Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 31. Global Oral Cholera Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 32. Global Oral Cholera Vaccine Price by Type (2016-2021e) & (USD/Unit)
Table 33. Global Oral Cholera Vaccine Price by Type (2021-2026) & (USD/Unit)
Table 34. Global Oral Cholera Vaccine Sales by Application (2016-2021e) & (K Units)
Table 35. Global Oral Cholera Vaccine Sales by Application (2021-2026) & (K Units)
Table 36. Global Oral Cholera Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 37. Global Oral Cholera Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 38. Global Oral Cholera Vaccine Price by Application (2016-2021e) & (USD/Unit)
Table 39. Global Oral Cholera Vaccine Price by Application (2021-2026) & (USD/Unit)
Table 40. North America Oral Cholera Vaccine Sales by Country (2016-2021e) & (K Units)
Table 41. North America Oral Cholera Vaccine Sales by Country (2021-2026) & (K Units)
Table 42. North America Oral Cholera Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 43. North America Oral Cholera Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 44. North America Oral Cholera Vaccine Sales by Type (2016-2021e) & (K Units)
Table 45. North America Oral Cholera Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. North America Oral Cholera Vaccine Sales by Application (2016-2021e) & (K Units)
Table 47. North America Oral Cholera Vaccine Sales by Application (2021-2026) & (K Units)
Table 48. Europe Oral Cholera Vaccine Sales by Country (2016-2021e) & (K Units)
Table 49. Europe Oral Cholera Vaccine Sales by Country (2021-2026) & (K Units)
Table 50. Europe Oral Cholera Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 51. Europe Oral Cholera Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 52. Europe Oral Cholera Vaccine Sales by Type (2016-2021e) & (K Units)
Table 53. Europe Oral Cholera Vaccine Sales by Type (2021-2026) & (K Units)
Table 54. Europe Oral Cholera Vaccine Sales by Application (2016-2021e) & (K Units)
Table 55. Europe Oral Cholera Vaccine Sales by Application (2021-2026) & (K Units)
Table 56. Asia-Pacific Oral Cholera Vaccine Sales by Region (2016-2021e) & (K Units)
Table 57. Asia-Pacific Oral Cholera Vaccine Sales by Region (2021-2026) & (K Units)
Table 58. Asia-Pacific Oral Cholera Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 59. Asia-Pacific Oral Cholera Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 60. Asia-Pacific Oral Cholera Vaccine Sales by Type (2016-2021e) & (K Units)
Table 61. Asia-Pacific Oral Cholera Vaccine Sales by Type (2021-2026) & (K Units)
Table 62. Asia-Pacific Oral Cholera Vaccine Sales by Application (2016-2021e) & (K Units)
Table 63. Asia-Pacific Oral Cholera Vaccine Sales by Application (2021-2026) & (K Units)
Table 64. South America Oral Cholera Vaccine Sales by Country (2016-2021e) & (K Units)
Table 65. South America Oral Cholera Vaccine Sales by Country (2021-2026) & (K Units)
Table 66. South America Oral Cholera Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 67. South America Oral Cholera Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 68. South America Oral Cholera Vaccine Sales by Type (2016-2021e) & (K Units)
Table 69. South America Oral Cholera Vaccine Sales by Type (2021-2026) & (K Units)
Table 70. South America Oral Cholera Vaccine Sales by Application (2016-2021e) & (K Units)
Table 71. South America Oral Cholera Vaccine Sales by Application (2021-2026) & (K Units)
Table 72. Middle East & Africa Oral Cholera Vaccine Sales by Country (2016-2021e) & (K Units)
Table 73. Middle East & Africa Oral Cholera Vaccine Sales by Country (2021-2026) & (K Units)
Table 74. Middle East & Africa Oral Cholera Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 75. Middle East & Africa Oral Cholera Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 76. Middle East & Africa Oral Cholera Vaccine Sales by Type (2016-2021e) & (K Units)
Table 77. Middle East & Africa Oral Cholera Vaccine Sales by Type (2021-2026) & (K Units)
Table 78. Middle East & Africa Oral Cholera Vaccine Sales by Application (2016-2021e) & (K Units)
Table 79. Middle East & Africa Oral Cholera Vaccine Sales by Application (2021-2026) & (K Units)
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. Oral Cholera Vaccine Typical Distributors
Table 83. Oral Cholera Vaccine Typical Customers
List of Figures
Figure 1. Oral Cholera Vaccine Picture
Figure 2. Global Oral Cholera Vaccine Sales Market Share by Type in 2020
Figure 3. Shanchol
Figure 4. Dukoral
Figure 5. Vaxchora
Figure 6. Others
Figure 7. Global Oral Cholera Vaccine Sales Market Share by Application in 2020
Figure 8. Hospital
Figure 9. Research & Academic Laboratories
Figure 10. Pharmaceutical & Biotechnology Companies
Figure 11. Others
Figure 12. Global Oral Cholera Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Oral Cholera Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Oral Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Oral Cholera Vaccine Sales (2016-2026) & (K Units)
Figure 34. Global Oral Cholera Vaccine Production Capacity (2016-2026) & (K Units)
Figure 35. Global Oral Cholera Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Oral Cholera Vaccine Market Drivers
Figure 37. Oral Cholera Vaccine Market Restraints
Figure 38. Oral Cholera Vaccine Market Trends
Figure 39. Global Oral Cholera Vaccine Sales Market Share by Manufacturer in 2020
Figure 40. Global Oral Cholera Vaccine Revenue Market Share by Manufacturer in 2020
Figure 41. Oral Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Oral Cholera Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Oral Cholera Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Oral Cholera Vaccine Sales Market Share by Region (2016-2026)
Figure 45. Global Oral Cholera Vaccine Revenue Market Share by Region (2016-2026)
Figure 46. North America Oral Cholera Vaccine Revenue (2016-2026) & (USD Million)
Figure 47. Europe Oral Cholera Vaccine Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Oral Cholera Vaccine Revenue (2016-2026) & (USD Million)
Figure 49. South America Oral Cholera Vaccine Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Oral Cholera Vaccine Revenue (2016-2026) & (USD Million)
Figure 51. Global Oral Cholera Vaccine Sales Market Share by Type (2016-2026)
Figure 52. Global Oral Cholera Vaccine Revenue Market Share by Type (2016-2026)
Figure 53. Global Oral Cholera Vaccine Price by Type (2016-2026) & (USD/Unit)
Figure 54. Global Oral Cholera Vaccine Sales Market Share by Application (2016-2026)
Figure 55. Global Oral Cholera Vaccine Revenue Market Share by Application (2016-2026)
Figure 56. Global Oral Cholera Vaccine Price by Application (2016-2026) & (USD/Unit)
Figure 57. North America Oral Cholera Vaccine Sales Market Share by Country (2016-2026)
Figure 58. North America Oral Cholera Vaccine Revenue Market Share by Country (2016-2026)
Figure 59. North America Oral Cholera Vaccine Sales Market Share by Type (2016-2026)
Figure 60. North America Oral Cholera Vaccine Sales Market Share by Application (2016-2026)
Figure 61. Europe Oral Cholera Vaccine Sales Market Share by Country (2016-2026)
Figure 62. Europe Oral Cholera Vaccine Revenue Market Share by Country (2016-2026)
Figure 63. Europe Oral Cholera Vaccine Sales Market Share by Type (2016-2026)
Figure 64. Europe Oral Cholera Vaccine Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Oral Cholera Vaccine Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Oral Cholera Vaccine Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Oral Cholera Vaccine Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Oral Cholera Vaccine Sales Market Share by Application (2016-2026)
Figure 69. South America Oral Cholera Vaccine Sales Market Share by Country (2016-2026)
Figure 70. South America Oral Cholera Vaccine Revenue Market Share by Country (2016-2026)
Figure 71. South America Oral Cholera Vaccine Sales Market Share by Type (2016-2026)
Figure 72. South America Oral Cholera Vaccine Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Oral Cholera Vaccine Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Oral Cholera Vaccine Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Oral Cholera Vaccine Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Oral Cholera Vaccine Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界のコレラワクチン（経口用）市場 2021：企業別、地域別、種類・用途別 The Cholera Vaccine (Oral Route) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…- 世界のコレラワクチン市場 2021：企業別、地域別、種類・用途別 The Cholera Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界のコレラ治療市場規模・現状・予測（2021年-2027年） Cholera is an infectious disease that causes severe watery diarrhea, which can lead to dehydration and even death if untreated. Market Analysis and Insights: Global Cholera Treatment Market The global Cholera Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in …
- 世界の腸チフスワクチン市場 2021：企業別、地域別、種類・用途別 The Typhoid Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…
- 世界の新型コロナウイルス感染症RNAワクチン市場規模・現状・予測（2021年-2027年） RNA vaccines are leading the way in vaccines because they are particularly well suited to rapid development.Although no RNA vaccine has yet been approved, the threat of a pandemic is a great incentive to accelerate its progress.RNA vaccines consist of mrna strands.They are injected into the body, us…